Literature DB >> 33711922

Improving high-resolution copy number variation analysis from next generation sequencing using unique molecular identifiers.

Pierre-Julien Viailly1,2, Vincent Sater3,4,5, Mathieu Viennot3,4, Elodie Bohers3,4, Nicolas Vergne6, Caroline Berard5, Hélène Dauchel5, Thierry Lecroq5, Alison Celebi3,4,7, Philippe Ruminy3,4, Vinciane Marchand3,4, Marie-Delphine Lanic3,4, Sydney Dubois3,4, Dominique Penther3,4, Hervé Tilly3,4, Sylvain Mareschal8, Fabrice Jardin3,4.   

Abstract

BACKGROUND: Recently, copy number variations (CNV) impacting genes involved in oncogenic pathways have attracted an increasing attention to manage disease susceptibility. CNV is one of the most important somatic aberrations in the genome of tumor cells. Oncogene activation and tumor suppressor gene inactivation are often attributed to copy number gain/amplification or deletion, respectively, in many cancer types and stages. Recent advances in next generation sequencing protocols allow for the addition of unique molecular identifiers (UMI) to each read. Each targeted DNA fragment is labeled with a unique random nucleotide sequence added to sequencing primers. UMI are especially useful for CNV detection by making each DNA molecule in a population of reads distinct.
RESULTS: Here, we present molecular Copy Number Alteration (mCNA), a new methodology allowing the detection of copy number changes using UMI. The algorithm is composed of four main steps: the construction of UMI count matrices, the use of control samples to construct a pseudo-reference, the computation of log-ratios, the segmentation and finally the statistical inference of abnormal segmented breaks. We demonstrate the success of mCNA on a dataset of patients suffering from Diffuse Large B-cell Lymphoma and we highlight that mCNA results have a strong correlation with comparative genomic hybridization.
CONCLUSION: We provide mCNA, a new approach for CNV detection, freely available at https://gitlab.com/pierrejulien.viailly/mcna/ under MIT license. mCNA can significantly improve detection accuracy of CNV changes by using UMI.

Entities:  

Keywords:  CNV calling; Next generation sequencing; UMI

Mesh:

Year:  2021        PMID: 33711922      PMCID: PMC7971104          DOI: 10.1186/s12859-021-04060-4

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  14 in total

1.  CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing.

Authors:  Alexej Abyzov; Alexander E Urban; Michael Snyder; Mark Gerstein
Journal:  Genome Res       Date:  2011-02-07       Impact factor: 9.043

2.  PRISM: pair-read informed split-read mapping for base-pair level detection of insertion, deletion and structural variants.

Authors:  Yue Jiang; Yadong Wang; Michael Brudno
Journal:  Bioinformatics       Date:  2012-07-31       Impact factor: 6.937

3.  Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study.

Authors:  Fabrice Jardin; Jean-Philippe Jais; Thierry-Jo Molina; Françoise Parmentier; Jean-Michel Picquenot; Philippe Ruminy; Hervé Tilly; Christian Bastard; Gilles-André Salles; Pierre Feugier; Catherine Thieblemont; Christian Gisselbrecht; Aurelien de Reynies; Bertrand Coiffier; Corinne Haioun; Karen Leroy
Journal:  Blood       Date:  2010-04-30       Impact factor: 22.113

4.  Gustaf: Detecting and correctly classifying SVs in the NGS twilight zone.

Authors:  Kathrin Trappe; Anne-Katrin Emde; Hans-Christian Ehrlich; Knut Reinert
Journal:  Bioinformatics       Date:  2014-07-14       Impact factor: 6.937

5.  Application of the cghRA framework to the genomic characterization of Diffuse Large B-Cell Lymphoma.

Authors:  Sylvain Mareschal; Philippe Ruminy; Marion Alcantara; Céline Villenet; Martin Figeac; Sydney Dubois; Philippe Bertrand; Abdelilah Bouzelfen; Pierre-Julien Viailly; Dominique Penther; Hervé Tilly; Christian Bastard; Fabrice Jardin
Journal:  Bioinformatics       Date:  2017-10-01       Impact factor: 6.937

6.  An improved approach for accurate and efficient calling of structural variations with low-coverage sequence data.

Authors:  Jin Zhang; Jiayin Wang; Yufeng Wu
Journal:  BMC Bioinformatics       Date:  2012-04-19       Impact factor: 3.169

7.  UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy.

Authors:  Tom Smith; Andreas Heger; Ian Sudbery
Journal:  Genome Res       Date:  2017-01-18       Impact factor: 9.043

8.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

9.  PEMer: a computational framework with simulation-based error models for inferring genomic structural variants from massive paired-end sequencing data.

Authors:  Jan O Korbel; Alexej Abyzov; Xinmeng Jasmine Mu; Nicholas Carriero; Philip Cayting; Zhengdong Zhang; Michael Snyder; Mark B Gerstein
Journal:  Genome Biol       Date:  2009-02-23       Impact factor: 13.583

10.  Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data.

Authors:  Valentina Boeva; Tatiana Popova; Maxime Lienard; Sebastien Toffoli; Maud Kamal; Christophe Le Tourneau; David Gentien; Nicolas Servant; Pierre Gestraud; Thomas Rio Frio; Philippe Hupé; Emmanuel Barillot; Jean-François Laes
Journal:  Bioinformatics       Date:  2014-07-12       Impact factor: 6.937

View more
  2 in total

1.  ifCNV: A novel isolation-forest-based package to detect copy-number variations from various targeted NGS datasets.

Authors:  Simon Cabello-Aguilar; Julie A Vendrell; Charles Van Goethem; Mehdi Brousse; Catherine Gozé; Laurent Frantz; Jérôme Solassol
Journal:  Mol Ther Nucleic Acids       Date:  2022-09-22       Impact factor: 10.183

Review 2.  cfDNA Sequencing: Technological Approaches and Bioinformatic Issues.

Authors:  Elodie Bohers; Pierre-Julien Viailly; Fabrice Jardin
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.